Perrone, Ronald D.

National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification

Levey, A. S., Coresh, J., Balk, E., Kausz, A. T., Levin, A., Steffes, M. W., Hogg, R. J., Perrone, R. D., Lau, J., & Eknoyan, G. (2003) · Annals of Internal Medicine

Chronic Kidney Disease and DiabetesAcute Kidney Injury Research

Cited by 4,615

Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease

Torres, V. E., Chapman, A. B., Devuyst, O., Gansevoort, R. T., Perrone, R. D., Koch, G., Ouyang, J., McQuade, R. D., Blais, J. D., Czerwiec, F. S., et al. (2017) · New England Journal of Medicine

Genetic and Kidney Cyst DiseasesChronic Kidney Disease and Diabetes

Cited by 639

Autosomal dominant polycystic kidney disease

Cornec-Le Gall, E., Alam, A., & Perrone, R. D. (2019) · The Lancet

Genetic and Kidney Cyst DiseasesTuberous Sclerosis Complex Research

Cited by 624

Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials

Heerspink, H. J. L., Greene, T., Tighiouart, H., Gansevoort, R. T., Coresh, J., Simon, A. L., Chan, T. M., Hou, F. F., Lewis, J. B., Locatelli, F., et al. (2019) · The Lancet Diabetes & Endocrinology

Chronic Kidney Disease and DiabetesStatistical Methods in Clinical Trials

Cited by 397

Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies

Coresh, J., Heerspink, H. J. L., Sang, Y., Matsushita, K., Arnlov, J., Astor, B. C., Black, C., Brunskill, N. J., Carrero, J.-J., Feldman, H. I., et al. (2019) · The Lancet Diabetes & Endocrinology

Chronic Kidney Disease and DiabetesAcute Kidney Injury Research

Cited by 338